Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control
Clinical trial NCT00697866 · COMPLETED
Trial details
- NCT number
- NCT00697866
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Primary completion
- 2001-02-01
- Enrollment
- 951
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.